Cite
HARVARD Citation
Moore, S. et al. (n.d.). 2440. Weight-Adjusted Piperacillin–Tazobactam (PIP/TAZ) Therapy in Obese Patients vs. Optimized Doses in Non-obese Patients: A Retrospective Cohort Study. Open forum infectious diseases. p. S730. [Online].